Hospital Medicine & Internal Medicine

December 12-15, 2022 | USA

Hospital_Medi_cine
Appraise the symptoms of congestive heart failure and detect the common causes of systolic heart failure. Employ the current standard-of-care therapies and Determine which patients will benefit from device therapy and specify when to refer patients for more advanced cardiac care.
Register Now

Spotlight

The first gene therapies are likely to enter use in the US health care system within the next 12-24 months. Many of these products will offer the potential of a short “one-off” treatment regimen promising lifelong benefits. However, evaluating the effectiveness and value of gene therapies at launch will be difficult, and their high cost is likely to present severe affordability challenges for payers and society, raising the question of whether new models of pricing and payment and new or modified HTA assessment methodologies are needed.


OTHER UPCOMING CONFERENCES

INTERNATIONAL CONFERENCE AND EXPO ON BIOTECHNOLOGY AND BIOENGINEERING

December 7-8, 2022 | Belgium

Hilaris Conferences invites all the participants from all over the world to attend "International conference and expo on Biotechnology and Bioengineering" on December 07-08, 2022 in Webinar.
Register Now

International Congress on Metabolomics and Systems Biology

November 30-December 1, 2022 | USA

Access to all conference sessions, poster and exhibition area Conference kit includes Name Tag, Program Booklet and Abstract Book All accepted Abstracts will be published in the conference souvenir
Register Now

International Congress on Urology and Andrology

November 30-December 1, 2022 | USA

Access to all conference sessions, poster and exhibition area Conference kit includes Name Tag, Program Booklet and Abstract Book All accepted Abstracts will be published in the conference souvenir
Register Now

BIO International Convention

June 5-8, 2023 | USA

Stand up for innovation. Stand up for truth. And stand up for science. It’s time to inspire, honor, and recognize the true value of the breakthrough work biotech performs for society.
Register Now

Spotlight

The first gene therapies are likely to enter use in the US health care system within the next 12-24 months. Many of these products will offer the potential of a short “one-off” treatment regimen promising lifelong benefits. However, evaluating the effectiveness and value of gene therapies at launch will be difficult, and their high cost is likely to present severe affordability challenges for payers and society, raising the question of whether new models of pricing and payment and new or modified HTA assessment methodologies are needed.

resources